Rxivist logo

Assessing The Efficiency Of Catch-Up Campaigns For Introduction Of Pneumococcal Conjugate Vaccine; A Modelling Study Based On Data From Kilifi, Kenya

By Stefan Flasche, John Ojal, Olivier Le Polain de Waroux, Mark O Otiende, Katherine L. O’Brien, Moses Kiti, James Nokes, W. John Edmunds, J. Anthony G. Scott

Posted 22 Mar 2017
bioRxiv DOI: 10.1101/118976 (published DOI: 10.1186/s12916-017-0882-9)

Background: The World Health Organisation recommends the use of catch-up campaigns as part of the introduction of pneumococcal conjugate vaccines (PCVs) to accelerate herd protection and hence PCV impact. The value of a catch-up campaign is a trade-off between the costs of vaccinating additional age groups and the benefit of additional direct and indirect protection. There is a paucity of observational data, particularly from low-middle income countries to quantify the optimal breadth of such catch-up campaigns. Methods: In Kilifi, Kenya PCV10 was introduced in 2011 using the 3-dose EPI infant schedule and a catch-up campaign in children <5 years old. We fitted a transmission dynamic model to detailed local data including nasopharyngeal carriage and invasive pneumococcal disease (IPD) to infer the marginal impact of the PCV catch-up campaign over hypothetical routine cohort vaccination in that setting, and to estimate the likely impact of alternative campaigns and their dose-efficiency. Results: We estimated that, within 10 years of introduction, the catch-up campaign among <5y olds prevents an additional 65 (48 to 84) IPD cases, compared to PCV cohort introduction alone. Vaccination without any catch-up campaign prevented 155 (121 to 193) IPD cases and used 1321 (1058 to 1698) PCV doses per IPD case prevented. In the years after implementation, the PCV programme gradually accrues herd protection and hence its dose-efficiency increases: 10 years after the start of cohort vaccination alone the programme used 910 (732 to 1184) doses per IPD case averted. We estimated that a two-dose catch-up among <1y olds uses an additional 910 (732 to 1184) doses per additional IPD case averted. Furthermore, by extending a single dose catch-up campaign to children 1 to <2y old and subsequently to 2 to <5y olds the campaign uses an additional 412 (296 to 606) and 543 (403 to 763) doses per additional IPD case averted. These results were not sensitive to vaccine coverage, serotype competition, the duration of vaccine protection or the relative protection of infants. Conclusions: We find that catch-up campaigns are a highly dose-efficient way to accelerate population protection against pneumococcal disease.

Download data

  • Downloaded 379 times
  • Download rankings, all-time:
    • Site-wide: 131,196
    • In epidemiology: 5,446
  • Year to date:
    • Site-wide: 198,379
  • Since beginning of last month:
    • Site-wide: 105,603

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide